Progress, challenges, and opportunities in two-dimensional materials beyond graphene
Graphene’s success has shown that it is possible to create stable, single and few-atom-thick
layers of van der Waals materials, and also that these materials can exhibit fascinating and …
layers of van der Waals materials, and also that these materials can exhibit fascinating and …
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
…, M Yuan, J Huang, Z Wang, J Yu… - Proceedings of the …, 2020 - National Acad Sciences
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019
(COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were …
(COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were …
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
…, T Wang, W Guo, J Chen, C Ding, X Zhang, J Huang… - bmj, 2020 - bmj.com
… N Engl J Med 2020;382:727-33. doi:10.1056/NEJMoa2001017 4 Gralinski LE,
Menachery VD. Return of the Coronavirus: 2019… Eur Heart J 2006;27:330-7. doi:10.1093/eurheartj/ehi631 …
Menachery VD. Return of the Coronavirus: 2019… Eur Heart J 2006;27:330-7. doi:10.1093/eurheartj/ehi631 …
[HTML][HTML] Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
Background Contemporary data for causes of vision impairment and blindness form an
important basis of recommendations in public health policies. Refreshment of the Global Vision …
important basis of recommendations in public health policies. Refreshment of the Global Vision …
[HTML][HTML] Towards 6G wireless communication networks: Vision, enabling technologies, and new paradigm shifts
The fifth generation (5G) wireless communication networks are being deployed worldwide
from 2020 and more capabilities are in the process of being standardized, such as mass …
from 2020 and more capabilities are in the process of being standardized, such as mass …
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group
…, FF Arhin, SJ Devi, CE Frasch, JC Huang… - Clinical Diagnostic …, 1997 - Am Soc Microbiol
A standardized serum bactericidal assay (SBA) is required to evaluate the functional activity
of antibody produced in response to Neisseria meningitidis serogroup A and C vaccines. …
of antibody produced in response to Neisseria meningitidis serogroup A and C vaccines. …
On the opportunities and risks of foundation models
AI is undergoing a paradigm shift with the rise of models (eg, BERT, DALL-E, GPT-3) that are
trained on broad data at scale and are adaptable to a wide range of downstream tasks. We …
trained on broad data at scale and are adaptable to a wide range of downstream tasks. We …
[HTML][HTML] The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung …
The IASLC Staging and Prognostic Factors Committee has collected a new database of
94,708 cases donated from 35 sources in 16 countries around the globe. This has now been …
94,708 cases donated from 35 sources in 16 countries around the globe. This has now been …
Global variation in copy number in the human genome
Copy number variation (CNV) of DNA sequences is functionally significant but has yet to be
fully ascertained. We have constructed a first-generation CNV map of the human genome …
fully ascertained. We have constructed a first-generation CNV map of the human genome …
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a …
…, M Ye, J Huang, X Zhi, Y Zhang, Q Xiu, J Ma… - The lancet …, 2011 - thelancet.com
Background Activating mutations in EGFR are important markers of response to tyrosine
kinase inhibitor (TKI) therapy in non-small-cell lung cancer (NSCLC). The OPTIMAL study …
kinase inhibitor (TKI) therapy in non-small-cell lung cancer (NSCLC). The OPTIMAL study …